LBDTAP Trademark

Trademark Overview

On Tuesday, February 23, 2021, a trademark application was filed for LBDTAP with the United States Patent and Trademark Office. The USPTO has given the LBDTAP trademark a serial number of 90541248. The federal status of this trademark filing is REGISTERED as of Tuesday, September 6, 2022. This trademark is owned by Amprion, Inc.. The LBDTAP trademark is filed in the Medical & Beauty Services & Agricultural Services category with the following description:

Medical diagnosis of neurodegenerative diseases
lbdtap

General Information

Serial Number90541248
Word MarkLBDTAP
Filing DateTuesday, February 23, 2021
Status700 - REGISTERED
Status DateTuesday, September 6, 2022
Registration Number6840497
Registration DateTuesday, September 6, 2022
Mark Drawing4000 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, April 19, 2022

Trademark Statements

Pseudo MarkLBD TAP
Goods and ServicesMedical diagnosis of neurodegenerative diseases

Classification Information

International Class044 - Medical services; veterinary services; hygienic and beauty care for human beings or animals; agriculture, horticulture and forestry services.
US Class Codes100, 101
Class Status Code6 - Active
Class Status DateMonday, May 24, 2021
Primary Code044
First Use Anywhere DateMonday, June 20, 2022
First Use In Commerce DateMonday, June 20, 2022

Trademark Owner History

Party NameAmprion, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105
Party NameAmprion, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressSan Francisco, CA 94105

Trademark Events

Event DateEvent Description
Tuesday, September 6, 2022NOTICE OF REGISTRATION CONFIRMATION EMAILED
Tuesday, September 6, 2022REGISTERED-PRINCIPAL REGISTER
Thursday, August 4, 2022NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Wednesday, August 3, 2022ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Friday, July 29, 2022STATEMENT OF USE PROCESSING COMPLETE
Wednesday, July 13, 2022USE AMENDMENT FILED
Thursday, July 28, 2022CASE ASSIGNED TO INTENT TO USE PARALEGAL
Wednesday, July 13, 2022TEAS STATEMENT OF USE RECEIVED
Tuesday, June 14, 2022NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Tuesday, April 19, 2022OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, April 19, 2022PUBLISHED FOR OPPOSITION
Wednesday, March 30, 2022NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, March 14, 2022ASSIGNED TO LIE
Friday, March 11, 2022APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, February 8, 2022TEAS/EMAIL CORRESPONDENCE ENTERED
Monday, February 7, 2022CORRESPONDENCE RECEIVED IN LAW OFFICE
Monday, February 7, 2022TEAS RESPONSE TO OFFICE ACTION RECEIVED
Monday, September 20, 2021NOTIFICATION OF NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION E-MAILED
Monday, September 20, 2021NON-FINAL ACTION WRITTEN
Friday, September 17, 2021ASSIGNED TO EXAMINER
Monday, May 24, 2021NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Friday, February 26, 2021NEW APPLICATION ENTERED

Related Keywords

lbdtap diseases neurodegenerative diagnosis medical